| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adaptive Immunity in Genitourinary Cancers
|
Koti, Madhuri
|
|
|
6 |
3 |
p. 263-272
|
artikel
|
| 2 |
Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-analysis
|
Cao, Brent
|
|
|
6 |
3 |
p. 237-250
|
artikel
|
| 3 |
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma
|
McGregor, Bradley
|
|
|
6 |
3 |
p. 339-348
|
artikel
|
| 4 |
An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study
|
Eldred-Evans, David
|
|
|
6 |
3 |
p. 295-302
|
artikel
|
| 5 |
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non–muscle-invasive Bladder Cancer
|
Inman, Brant A.
|
|
|
6 |
3 |
p. 313-320
|
artikel
|
| 6 |
Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma
|
Khene, Zine-Eddine
|
|
|
6 |
3 |
p. 323-330
|
artikel
|
| 7 |
A Systematic Review of Oncological Outcomes Associated with Bladder-sparing Strategies in Patients Achieving Complete Clinical Response to Initial Systemic Treatment for Localized Muscle-invasive Bladder Cancer
|
Grobet-Jeandin, Elisabeth
|
|
|
6 |
3 |
p. 251-262
|
artikel
|
| 8 |
Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer
|
Gregg, Justin R.
|
|
|
6 |
3 |
p. 282-288
|
artikel
|
| 9 |
Contents
|
|
|
|
6 |
3 |
p. iii-v
|
artikel
|
| 10 |
Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma
|
Mason, Neil T.
|
|
|
6 |
3 |
p. 331-338
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
6 |
3 |
p. i-ii
|
artikel
|
| 12 |
Estimating the Effectiveness of Kidney Cancer Screening Within Lung Cancer Screening Programmes: A Validation in UK Biobank
|
Harrison, Hannah
|
|
|
6 |
3 |
p. 351-353
|
artikel
|
| 13 |
Health-related Quality of Life and Cost Effectiveness of Treatment: Components to Be Included in Clinical Decision-making
|
Bergerot, Cristiane Decat
|
|
|
6 |
3 |
p. 349-350
|
artikel
|
| 14 |
Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers
|
Bellone, Matteo
|
|
|
6 |
3 |
p. 273-274
|
artikel
|
| 15 |
Local Failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion
|
Gorovets, Daniel
|
|
|
6 |
3 |
p. 275-281
|
artikel
|
| 16 |
Oncological and Functional Outcomes for Men Undergoing Salvage Whole-gland Cryoablation for Radiation-resistant Prostate Cancer
|
Tan, Wei Phin
|
|
|
6 |
3 |
p. 289-294
|
artikel
|
| 17 |
Re: Wei Shan Tan, Gary Steinberg, J. Alfred Witjes, et al. Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol 2022;5:505–16
|
Montorsi, Francesco
|
|
|
6 |
3 |
p. 354
|
artikel
|
| 18 |
Salvage Reirradiation Options for Treating Local Recurrence After Previous Prostatectomy and Radiotherapy: Where Do We Stand?
|
Zhong, Jim
|
|
|
6 |
3 |
p. 311-312
|
artikel
|
| 19 |
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study
|
Archer, Paul
|
|
|
6 |
3 |
p. 303-310
|
artikel
|
| 20 |
The Pursuit of Intravesical and Systemic Therapies in Non–muscle-invasive Bladder Cancer: Challenges and Opportunities
|
Ghali, Fady
|
|
|
6 |
3 |
p. 321-322
|
artikel
|
Tijdschrift beschrijving